Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 34 Lung Neoplasms 29 Ovarian Neoplasms 23 Carcinoma, Ovarian Epithelial 18 Fallopian Tube Neoplasms 15 Adenocarcinoma of Lung 14 Neuroblastoma 13 Central Nervous System Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 8 Head and Neck Neoplasms 8 Brain Neoplasms 8 Brenner Tumor 7 Adenocarcinoma, Bronchiolo-Alveolar 7 Urinary Bladder Neoplasms 6 Urethral Neoplasms 5 Breast Neoplasms 5 Astrocytoma 5 Wilms Tumor 4 Uterine Cervical Neoplasms 4 Prostatic Neoplasms 4 Medulloblastoma 4 Teratoma 3 Radiation Injuries 3 Optic Nerve Glioma 3 Lymphoma 3 Esophageal Neoplasms 3 Carcinoma, Renal Cell 3 Carcinoma, Embryonal 3 Carcinoma 3 Thymoma 2

Interventions

Fluorouracil 6 Cisplatin 4 Radiotherapy 3 Mitomycin 3 dehydroftorafur 2 Radiotherapy, Intensity-Modulated 2 Cetuximab 2 Capecitabine 2 Taxes 1 Specimen Handling 1 Platinum 1 Paclitaxel 1 Mitozytrex 1 Magnetic Resonance Spectroscopy 1 Fluorodeoxyglucose F18 1 Carboplatin 1 Biopsy 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Anal Canal Carcinoma × Carboplatin × Clear all

NCT02560298 2023-06-22

InterAACT

Eastern Cooperative Oncology Group

Phase 2 Unknown

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡